Restless Leg Syndrome Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Restless Leg Syndrome Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Delveinsight Business Research LLP

DelveInsight’s “Restless Leg Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Restless Leg Syndrome, historical and forecasted epidemiology as well as the Restless Leg Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Restless legs syndrome (RLS), also called Willis-Ekbom Disease, causes unpleasant or uncomfortable sensations in the legs and an irresistible urge to move them. Symptoms commonly occur in the late afternoon or evening hours, and are often most severe at night when a person is resting, such as sitting or lying in bed. 

In most cases, the cause of RLS is unknown (called primary RLS). However, RLS has a genetic component and can be found in families where the onset of symptoms is before age 40. Specific gene variants have been associated with RLS. Restless legs syndrome (RLS) is known to occur secondary to various medical conditions such as iron deficiency, pregnancy, end-stage renal disease, and neuropathy. 

Get FREE sample copy at:

The Restless Leg Syndrome market report also covers emerging drugs, current treatment practices, Restless Leg Syndrome market share of the individual therapies, current and forecasted Restless Leg Syndrome Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Restless Leg Syndrome treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Restless Leg Syndrome Market Key Facts

  • Population-based studies using the full standard diagnostic criteria for RLS report a prevalence of 5% to 10% in western industrial countries, but a lower prevalence in Asian populations. [REST General Population Study, 2003]

  • According to the National Institutes of Health, it is estimated that up to 7-10 percent of the U.S. population may have Restless Legs Syndrome. It may begin at any age. Many individuals who are severely affected are middle-aged or older, and the symptoms typically become more frequent and last longer with age. More than 80 percent of people with RLS also experience periodic limb movement of sleep (PLMS).

Key Benefits of Restless Leg Syndrome Market Report

  • Restless Leg Syndrome market report provides an in-depth analysis of Restless Leg Syndrome Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Restless Leg Syndrome market report will help in developing business strategies by understanding the Restless Leg Syndrome Market trends & developments, key players, and future market competition that will shape and drive the Restless Leg Syndrome market in the upcoming years.

  • The Restless Leg Syndrome market report covers Restless Leg Syndrome current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Restless Leg Syndrome market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Restless Leg Syndrome Market

Restless Leg Syndrome market size shall grow during the forecast period owing to change in methodologies, incremental healthcare spending across the world, and also the expected launch of emerging therapies in the coming years. 

The Restless Leg Syndrome market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Restless Leg Syndrome market trends by analysing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Restless Leg Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Restless Leg Syndrome Epidemiology

The Restless Leg Syndrome epidemiology section covers insights about the historical and current Restless Leg Syndrome patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Restless Leg Syndrome Drugs Uptake and Key Market Players

The Restless Leg Syndrome Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Restless Leg Syndrome market or expected to get launched in the market during the study period. The analysis covers Restless Leg Syndrome market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The current pipeline for Restless Legs Syndrome does not hold many significant products, it has very few products that are being developed by certain key players.

Restless Leg Syndrome Companies:
Bioprojet Pharma
American Regent
Luye Pharma Goup
Boehringer Ingelheim
And many others.

Restless Leg Syndrome Therapies covered in the report include:
BPI 4979
LY 03009
Enacarbil (Horizant)
Pramipexole (Mirapex)
And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Restless Leg Syndrome Competitive Intelligence Analysis

4. Restless Leg Syndrome Market Overview at a Glance

5. Restless Leg Syndrome Disease Background and Overview

6. Restless Leg Syndrome Patient Journey

7. Restless Leg Syndrome Epidemiology and Patient Population

8. Restless Leg Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

9. Restless Leg Syndrome Unmet Needs

10. Key Endpoints of Restless Leg Syndrome Treatment

11. Restless Leg Syndrome Marketed Products

12. Restless Leg Syndrome Emerging Therapies

13. Restless Leg Syndrome Seven Major Market Analysis

14. Attribute Analysis

15. Restless Leg Syndrome Market Outlook (7 major markets)

16. Restless Leg Syndrome Access and Reimbursement Overview

17. KOL Views on the Restless Leg Syndrome Market.

18. Restless Leg Syndrome Market Drivers

19. Restless Leg Syndrome Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer
*The table of contents is not exhaustive; the final content may vary. 

Latest Reports By DelveInsight –
Balloon Valvuloplasty Device Market
DelveInsight’s ‘‘Balloon Valvuloplasty Device Market Insights, Competitive Landscape and Market Forecast-2025″ report deliver an in-depth understanding of Balloon Valvuloplasty Device and the historical and forecasted Balloon Valvuloplasty Device market trends in the US, EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.

Healthcare Blogs – 
Sleep Disorders Market:-
Over the past few years, sleep disorders have emerged as a key public health issue affecting the mental and physical well being of the person. However, to tackle sleep disorders, companies in the market such as Apnimed, Avadel Pharmaceuticals, Bayer Pharmaceuticals, Eisai US, Evotec, Idorsia Pharmaceuticals, Minerva Neurosciences and others are diligently involved in the therapeutics development. To read more visit: Types of Sleep Disorders and Treatment Options.

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States